$ANAB
AnaptysBio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$55.20
▲+0.25%+$0.140
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAnaptysBio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ANAB up today? It is at $55.20 (+0.25%), and our scanner flagged it 33 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ANAB spikes, and full due diligence on ANAB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ANAB 33 times in the last 30 days. Create a free account to track $ANAB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ANAB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ANAB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 17, 2026 · 3 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Orwin John A Director | Other | 1K | added 7.8% | 18K | n/a | Sep 15, 26 |
Orwin John A Director | Other | 6K 0.02% of company | added 57% | 17K | n/a | Jun 15, 26 |
Renton Hollings Director | Other | 6K 0.02% of company | added 100% | 11K | n/a | Jun 15, 26 |
Schmid John P. Director | Other | 6K 0.02% of company | added 19% | 38K | n/a | Jun 15, 26 |
Schmid John P. Director | Sold (automatic/other) | -21K 0.07% of company | sold 39% | 32K | $1.2M at $55.71 | Mar 30, 26 |
Faga Daniel Officer | Sold (automatic/other) | -18K 0.06% of company | sold 3.4% | 496K | $1.0M at $56.61 | Mar 27, 26 |
Faga Daniel Officer | Acquired (grant/award) | +34K 0.1% of company | added 7.2% | 514K | n/a | Mar 25, 26 |
Loumeau Eric J Officer | Sold (automatic/other) | -10K 0.03% of company | sold 44% | 13K | $540K at $54.00 | Feb 11, 26 |
Loumeau Eric J Officer | Other | 10K 0.03% of company | added 78% | 23K | $297K at $29.70 | Feb 11, 26 |
Marquet Magda Director | Sold (automatic/other) | -11K 0.04% of company | sold 53% | 10K | $529K at $48.12 | Jan 15, 26 |
Marquet Magda Director | Other | 11K 0.04% of company | added 100% | 21K | $287K at $26.11 | Jan 15, 26 |
Faga Daniel Officer | Sold (automatic/other) | -14K 0.05% of company | sold 2.9% | 479K | $639K at $44.71 | Jan 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ANAB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ANAB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ANAB last traded at $55.20, up 0.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
AnaptysBio, Inc. Common Stock (ANAB) is next expected to report earnings on Wednesday, September 23, 2026, about 3 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ANAB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ANAB 33 times in the last 30 days.
ANAB (AnaptysBio, Inc. Common Stock) trades on XNAS, with a market cap of about $1.61B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ANAB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ANAB discussion
Sign in to ask a question or join the discussion.